OKTA vs VNDA · P/E 84, rev $1.57B vs rev $102.2M
Okta Inc (OKTA) versus Vanda Pharmaceuticals Inc (VNDA) — a side-by-side from cached financials, not a winner call.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Vanda Pharmaceuticals Inc (VNDA) is a biotechnology company listed on NASDAQ.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
Latest reported VNDA revenue for 2026-06-30 was $102.2M. Net income was -$111.1M. Revenue was up 97.7% from 2026-03-31 to 2026-06-30. VNDA currently screens at market cap $358.4M.
OKTA currently screens at market cap $20.06B and trailing P/E 83.6. VNDA currently screens at market cap $358.4M.
Not investment advice. Open the OKTA and VNDA stock pages for the full models.
Not investment advice.